Molecular Analysis and Antimicrobial Resistance Pattern of Tigecycline-Non-Susceptible K. pneumoniae Isolated from a Tertiary Care Hospital of East Asia

References

• Ko WC, Paterson DL, Sagnimeni AJ, et al. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis. 2002;8:160–166. doi:10.3201/eid0802.01002511897067
   PubMed Web of Science ®Google Scholar
• Siu LK, Yeh KM, Lin JC, Fung CP, Chang FY. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012;12:881–887. doi:10.1016/S1473-3099(12)70205-023099082
   PubMed Web of Science ®Google Scholar
• Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785–796. doi:10.1016/S1473-3099(13)70190-723969216
   PubMed Web of Science ®Google Scholar
• Slover CM, Rodvold KA, Danziger LH. Tigecycline: a novel broad-spectrum antimicrobial. Ann Pharmacother. 2007;41:965–972. doi:10.1345/aph.1H54317519296
   PubMed Web of Science ®Google Scholar
• Zhong X, Xu H, Chen D, Zhou H, Hu X, Cheng G. First emergence of acrAB and oqxAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese hospital. PLoS One. 2014;9:e115185. doi:10.1371/journal.pone.011518525503276
   PubMed Web of Science ®Google Scholar
• Lee CR, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol. 2016;7:895. doi:10.3389/fmicb.2016.0089527379038
   PubMed Web of Science ®Google Scholar
• Cheng YH, Huang TW, Juan CH, et al. Tigecycline-non-susceptible hypervirulent Klebsiella pneumoniae strains in Taiwan. J Antimicrob Chemother. 2020;75:309–317. doi:10.1093/jac/dkz45031702790
   PubMed Web of Science ®Google Scholar
• Xu H, Zhou Y, Zhai X, et al. Emergence and characterization of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae isolates from blood samples of patients in intensive care units in northern China. J Med Microbiol. 2016;65:751–759. doi:10.1099/jmm.0.00029927324378
   PubMed Web of Science ®Google Scholar
• Jeong SH, Kim HS, Kim JS, et al. Prevalence and molecular characteristics of carbapenemase-producing Enterobacteriaceae from five hospitals in Korea. Ann Lab Med. 2016;36:529–535. doi:10.3343/alm.2016.36.6.52927578505
   PubMed Web of Science ®Google Scholar
• Hladicz A, Kittinger C, Zarfel G. Tigecycline resistant Klebsiella pneumoniae isolated from Austrian River Water. Int J Environ Res Public Health. 2017;14:1169. doi:10.3390/ijerph14101169
   Web of Science ®Google Scholar
• Chiu SK, Huang LY, Chen H, et al. Roles of ramR and tet(A) mutations in conferring tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae clinical isolates. Antimicrob Agents Chemother. 2017;61. doi:10.1128/AAC.00391-17
   Web of Science ®Google Scholar
• Villa L, Feudi C, Fortini D, Garcia-Fernandez A, Carattoli A. Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance. Antimicrob Agents Chemother. 2014;58:1707–1712. doi:10.1128/AAC.01803-1324379204
   PubMed Web of Science ®Google Scholar
• Moore IF, Hughes DW, Wright GD. Tigecycline is modified by the flavin-dependent monooxygenase TetX. Biochemistry. 2005;44:11829–11835. doi:10.1021/bi050606616128584
   PubMed Web of Science ®Google Scholar
• Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43:4178–4182. doi:10.1128/JCM.43.8.4178-4182.200516081970
   PubMed Web of Science ®Google Scholar
• Gona F, Comandatore F, Battaglia S, et al. Comparison of core-genome MLST, coreSNP and PFGE methods for Klebsiella pneumoniae cluster analysis. Microb Genom. 2020;6. doi:10.1099/mgen.0.000347
   Web of Science ®Google Scholar
• Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9:228–236. doi:10.1016/S1473-3099(09)70054-419324295
   PubMed Web of Science ®Google Scholar
• Neuner EA, Yeh JY, Hall GS, et al. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis. 2011;69:357–362. doi:10.1016/j.diagmicrobio.2010.10.01321396529
   PubMed Web of Science ®Google Scholar
• Pournaras S, Koumaki V, Spanakis N, Gennimata V, Tsakris A. Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance. Int J Antimicrob Agents. 2016;48:11–18. doi:10.1016/j.ijantimicag.2016.04.01727256586
   PubMed Web of Science ®Google Scholar
• Wang X, Chen H, Zhang Y, et al. Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: role of the global regulator RamA and its local repressor RamR. Int J Antimicrob Agents. 2015;45:635–640. doi:10.1016/j.ijantimicag.2014.12.02225681067
   PubMed Web of Science ®Google Scholar
• Veleba M, Higgins PG, Gonzalez G, Seifert H, Schneiders T. Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2012;56:4450–4458. doi:10.1128/AAC.00456-1222644028
   PubMed Web of Science ®Google Scholar
• Yu X, Zhang W, Zhao Z, et al. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae isolates with focus on antimicrobial resistance. BMC Genomics. 2019;20:822. doi:10.1186/s12864-019-6225-931699025
   PubMed Web of Science ®Google Scholar
• Zeng L, Deng Q, Zeng T, Liu Y, Zhang J, Cao X. Prevalence of carbapenem-resistant Klebsiella pneumoniae infection in Southern China: clinical characteristics, antimicrobial resistance, virulence, and geographic distribution. Microb Drug Resist. 2020;26:483–491. doi:10.1089/mdr.2018.040131682180
   PubMed Web of Science ®Google Scholar
• Chung HS, Yong D, Lee M. Mechanisms of ertapenem resistance in Enterobacteriaceae isolates in a tertiary university hospital. J Investig Med. 2016;64:1042–1049. doi:10.1136/jim-2016-000117
   Web of Science ®Google Scholar
• Wu JJ, Wang LR, Liu YF, Chen HM, Yan JJ. Prevalence and characteristics of ertapenem-resistant Klebsiella pneumoniae isolates in a Taiwanese university hospital. Microb Drug Resist. 2011;17:259–266. doi:10.1089/mdr.2010.011521352075
   PubMed Web of Science ®Google Scholar
• Candan ED, Aksoz N. Klebsiella pneumoniae: characteristics of carbapenem resistance and virulence factors. Acta Biochim Pol. 2015;62:867–874. doi:10.18388/abp.2015_114826637376
   PubMed Web of Science ®Google Scholar
• Yu WL, Ko WC, Cheng KC, et al. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin Infect Dis. 2006;42:1351–1358. doi:10.1086/50342016619144
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu PP, Wang LH, Wei DD, Wan LG, Zhang W. Capsular polysaccharide types and virulence-related traits of epidemic KPC-producing Klebsiella pneumoniae isolates in a Chinese University Hospital. Microb Drug Resist. 2017;23:901–907. doi:10.1089/mdr.2016.022228437231
   PubMed Web of Science ®Google Scholar
• Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother. 2011;66:307–312. doi:10.1093/jac/dkq43121131324
   PubMed Web of Science ®Google Scholar
• Liu L, Feng Y, Tang G, et al. Carbapenem-resistant isolates of the Klebsiella pneumoniae complex in Western China: the common ST11 and the surprising hospital-specific types. Clin Infect Dis. 2018;67:S263–S265. doi:10.1093/cid/ciy66230423053
   PubMed Web of Science ®Google Scholar
• Yan WJ, Jing N, Wang SM, et al. Molecular characterization of carbapenem-resistant Enterobacteriaceae and emergence of tigecycline non-susceptible strains in the Henan province in China: a multicenter study. J Med Microbiol. 2021;70. doi:10.1099/jmm.0.001325
   Web of Science ®Google Scholar